Please Wait.....
Report
Drug Discovery Services Market research report Forecast to 2030
Market Report I 2023-03-17 I 110 Pages I Market Research Future
Drug Discovery Services Market research report Forecast to 2030
Market Overview
The Drug Discovery Services market industry is projected to exhibit a significant CAGR of 13.92% during the forecast period. Developing Re-appropriating of Drug Advancement and Expanding Exploration and Improvement Expenses are the key market drivers upgrading the Drug Discovery Services market development.
Drug and biopharmaceutical organizations are picking completely coordinated or practical rethinking services for drug innovative work from the early improvement stage to the late-stage advancement stage due to expanded Research and development consumptions. While drug organizations are under extraordinary strain to monitor fixed costs, re-appropriating has arisen as a strategic answer for the absence of inside assets required for new item improvement. Enormous pharma firms are changing to a more streamlined corporate methodology that unequivocally stresses rethinking.
Expanding need for imaginative therapeutics across a scope of restorative objectives. Drug-finding services Rising requirement for imaginative therapies for constant sicknesses and headways in the medical care industry are anticipated to be the primary drivers of market development. Drug and biopharmaceutical organizations actually contract their innovative work (Research and Development) activities to CROs, who offer Research and development services and make commitment models to boost Research and development productivity. Legislatures and drug enterprises are compelled to search for answers and lift their interest in clinical preliminaries because of the expanded weight of persistent sicknesses. Subsequently, there will be a more prominent requirement for drug discovery services.
Market Segmentation
Based on Drug Type, the Drug Discovery Services market has been classified into Small Molecule Drugs, Biologics' Based on type, the market is divided into Drug metabolism and pharmacokinetics (DMPK) Services, Pharmaceutical Services, and Others. Therapeutic Areas of the Drug Discovery Services market are bifurcated into data into Oncology, Others.
Regional Analysis
North America is likely to drive the global Drug Discovery Services market due to the higher interest in drug discovery Research and development, critical firms with laid-out research foundations, and specialized upgrades. As rethinking is at this point not just about reducing expenses, a developing requirement for viability, quality, and development is expected to help industry extension.
The Asia Pacific drug discovery services market is anticipated to develop the highest growth owing to the accessibility of qualified individuals, less expensive costs, a successful administrative climate, and great information, the Region is rapidly turning into a center for re-appropriating drug improvement exercises. The second-biggest drug market on the planet, Japan, is expected to furnish CROs with a sizable potential, driving the business.
The fast improvement of innovation and the development of metropolitan regions impel the European drug discovery services market. The improvement of biologics and biosimilars has seen an expansion in speculation from biopharmaceutical firms, which is liable for the ascent in the number of approved drugs in Europe. The European drug discovery services market is expected to be driven by expanding consumptions made by many significant organizations in different clinical and non-clinical examination exercises that are moved to a few CRO specialist co-ops and help with proficient item improvement.
Major Players
Abbott Laboratories Inc., Advinus Therapeutics, Albany Molecular Research Inc. (AMRI), Aurigene, Agilent Technologies Ubiquigent, AstraZeneca PLC, Retrogenix (U.K.), Charles River Laboratories International, Eurofins, and Liverpool ChiroChem Ltd.
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 OVERVIEW
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING RESEARCH & DEVELOPMENT EXPENDITURE
4.2.2 RISING DRUG DEVELOPMENT OUTSOURCING
4.3 RESTRAINTS
4.3.1 STRINGENT REGULATORY POLICIES AND COSTS ASSOCIATED TO DRUG DISCOVERY
4.4 OPPORTUNITY
4.4.1 TECHNOLOGICAL ADVANCEMENTS IN DRUG DISCOVERY
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 CUSTOMER ACQUISITION (PREPURCHASE QUERY)
5.1.2 SERVICE CUSTOMIZATION
5.1.2.1 R&D
5.1.2.2 GOOD LABORATORY PRACTICES (GLP)
5.1.3 CUSTOMER PURCHASE SUPPORT
5.1.4 CUSTOMER FULFILMENT & POST-PURCHASE SUPPORT
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
5.3 COVID-19 IMPACT ON THE DRUG DISCOVERY SERVICES MARKET
5.3.1 IMPACT ON R&D
5.3.2 IMPACT ON PRICING
5.3.3 IMPACT ON MARKET GROWTH
6 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE
6.1 OVERVIEW
6.2 SMALL MOLECULE DRUG
6.3 BIOLOGICS DRUG
7 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES
7.1 OVERVIEW
7.2 DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES
7.3 PHARMACEUTICAL SERVICES
7.4 MEDICINAL CHEMISTRY
7.5 BIOLOGICAL SERVICES
7.6 MEDICATION
8 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA
8.1 OVERVIEW
8.2 ONCOLOGY
8.3 CARDIOVASCULAR DISEASES
8.4 RESPIRATORY DISEASES
8.5 DIABETES
8.6 OTHERS
9 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY
9.1 OVERVIEW
9.2 HIGH THROUGHPUT SCREENING
9.3 BIOCHIPS
9.4 PHARMACOGENOMICS AND PHARMACOGENETICS
9.5 METABOLOMICS
9.6 OTHERS
10 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY END USER
10.1 OVERVIEW
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.3 RESEARCH & ACADEMIC INSTITUTES
10.4 OTHERS
11 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY REGION
11.1 OVERVIEW
11.2 NORTH AMERICA
11.2.1 US
11.2.2 CANADA
11.3 EUROPE
11.3.1 GERMANY
11.3.2 FRANCE
11.3.3 UK
11.3.4 ITALY
11.3.5 SPAIN
11.3.6 REST OF EUROPE
11.4 ASIA-PACIFIC
11.4.1 CHINA
11.4.2 JAPAN
11.4.3 INDIA
11.4.4 AUSTRALIA
11.4.5 SOUTH KOREA
11.4.6 REST OF ASIA-PACIFIC
11.5 REST OF THE WORLD
11.5.1 MIDDLE EAST
11.5.2 AFRICA
11.5.3 LATIN AMERICA
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 COMPETITIVE BENCHMARKING
12.3 MAJOR GROWTH STRATEGY IN DRUG DISCOVERY SERVICES MARKET
12.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN DRUG DISCOVERY SERVICES MARKET
12.5 KEY DEVELOPMENTS & GROWTH STRATEGIES
12.5.1 SERVICE LAUNCH
12.5.2 MERGERS & ACQUISITIONS
12.5.3 PARTNERSHIP/COLLABORATION
12.6 MAJOR PLAYERS SALES ANALYSIS
12.6.1 SALES & OPERATING INCOME, 2021 (USD MILLION)
12.6.2 MAJOR PLAYERS R&D ANALYSIS, 2021 (USD MILLION)
13 COMPANY PROFILE
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 COMPANY OVERVIEW
13.1.2 FINANCIAL OVERVIEW
13.1.3 SERVICES OFFERED
13.1.4 KEY DEVELOPMENTS
13.1.5 SWOT ANALYSIS
13.1.6 KEY STRATEGIES
13.2 ARAGEN LIFE SCIENCES PVT. LTD.
13.2.1 COMPANY OVERVIEW
13.2.2 FINANCIAL OVERVIEW
13.2.3 SERVICES OFFERED
13.2.4 KEY DEVELOPMENTS
13.2.5 KEY STRATEGIES
13.3 PIRAMAL PHARMA SOLUTIONS
13.3.1 COMPANY OVERVIEW
13.3.2 FINANCIAL OVERVIEW
13.3.3 SERVICES OFFERED
13.3.4 KEY DEVELOPMENTS
13.3.5 KEY STRATEGIES
13.4 CURIA GLOBAL, INC.
13.4.1 COMPANY OVERVIEW
13.4.2 FINANCIAL OVERVIEW
13.4.3 SERVICES OFFERED
13.4.4 KEY STRATEGIES
13.5 CHARLES RIVER LABORATORIES
13.5.1 COMPANY OVERVIEW
13.5.2 FINANCIAL OVERVIEW
13.5.3 SERVICES OFFERED
13.5.4 KEY DEVELOPMENTS
13.5.5 SWOT ANALYSIS
13.5.6 KEY STRATEGIES
13.6 EUROFINS SCIENTIFIC
13.6.1 COMPANY OVERVIEW
13.6.2 FINANCIAL OVERVIEW
13.6.3 SERVICES OFFERED
13.6.4 KEY DEVELOPMENTS
13.6.5 SWOT ANALYSIS
13.6.6 KEY STRATEGIES
13.7 IQVIA
13.7.1 COMPANY OVERVIEW
13.7.2 FINANCIAL OVERVIEW
13.7.3 SERVICES OFFERED
13.7.4 KEY DEVELOPMENTS
13.7.5 SWOT ANALYSIS
13.7.6 KEY STRATEGIES
13.8 EVOTEC
13.8.1 COMPANY OVERVIEWS
13.8.2 FINANCIAL OVERVIEW
13.8.3 SERVICES OFFERED
13.8.4 KEY DEVELOPMENTS
13.8.5 KEY STRATEGIES
13.9 WUXI APPTEC CO., LTD.
13.9.1 COMPANY OVERVIEW
13.9.2 FINANCIAL OVERVIEW
13.9.3 SERVICES OFFERED
13.9.4 KEY DEVELOPMENTS
13.9.5 SWOT ANALYSIS
13.9.6 KEY STRATEGIES
13.10 LABORATORY CORPORATION OF AMERICA HOLDINGS
13.10.1 COMPANY OVERVIEW
13.10.1 FINANCIAL OVERVIEW
13.10.2 SERVICES OFFERED
13.10.3 KEY DEVELOPMENTS
13.10.4 KEY STRATEGIES
13.11 SELVITA
13.11.1 COMPANY OVERVIEW
13.11.2 FINANCIAL OVERVIEW
13.11.3 SERVICES OFFERED
13.11.4 KEY DEVELOPMENTS
13.11.5 SWOT ANALYSIS
13.11.6 KEY STRATEGIES
13.12 SYGNATURE DISCOVERY
13.12.1 COMPANY OVERVIEW
13.12.2 FINANCIAL OVERVIEW
13.12.3 SERVICES OFFERED
13.12.4 KEY DEVELOPMENTS
13.12.5 SWOT ANALYSIS
13.12.6 KEY STRATEGIES
13.13 SYMERES
13.13.1 COMPANY OVERVIEW
13.13.2 FINANCIAL OVERVIEW
13.13.3 SERVICES OFFERED
13.13.4 KEY DEVELOPMENTS
13.13.5 SWOT ANALYSIS
13.13.6 KEY STRATEGIES
13.14 NUCHEM SCIENCES INC.
13.14.1 COMPANY OVERVIEW
13.14.2 FINANCIAL OVERVIEW
13.14.3 SERVICES OFFERED
13.14.4 KEY STRATEGIES
13.15 PARAZA PHARMA, INC.
13.15.1 COMPANY OVERVIEW
13.15.2 FINANCIAL OVERVIEW
13.15.3 SERVICES OFFERED
13.15.4 KEY DEVELOPMENTS
13.15.5 KEY STRATEGIES
14 APPENDIX
14.1 REFERENCES
14.2 RELATED REPORTS
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
TABLE 3 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 4 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR SMALL MOLECULE DRUG, BY REGION, 2023-2030 (USD MILLION)
TABLE 5 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR BIOLOGICS DRUG, BY REGION, 2023-2030 (USD MILLION)
TABLE 6 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2023-2030 (USD MILLION)
TABLE 7 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR DRUG METABOLISM AND PHARMACOKINETICS (DMPK) SERVICES, BY REGION, 2023-2030 (USD MILLION)
TABLE 8 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR PHARMACEUTICAL SERVICES, BY REGION, 2023-2030 (USD MILLION)
TABLE 9 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR MEDICINAL CHEMISTRY, BY REGION, 2023-2030 (USD MILLION)
TABLE 10 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR BIOLOGICAL SERVICES, BY ERGION, 2023-2030 (USD MILLION)
TABLE 11 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR MEDICATION, BY REGION, 2023-2030 (USD MILLION)
TABLE 12 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 13 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR ONCOLOGY, BY REGION, 2023-2030 (USD MILLION)
TABLE 14 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR CARDIOVASCULAR DISEASES, BY REGION, 2023-2030 (USD MILLION)
TABLE 15 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR RESPIRATORY DISEASES, BY REGION, 2023-2030 (USD MILLION)
TABLE 16 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR DIABETES, BY REGION, 2023-2030 (USD MILLION)
TABLE 17 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR OTHERS, BY REGION, 2023-2030 (USD MILLION)
TABLE 18 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 19 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR HIGH THROUGHPUT SCREENING COMPANIES, BY REGION, 2023-2030 (USD MILLION)
TABLE 20 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR BIOCHIPS, BY REGION, 2023-2030 (USD MILLION)
TABLE 21 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR PHARMACOGENOMICS AND PHARMACOGENETICS, BY REGION, 2023-2030 (USD MILLION)
TABLE 22 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR METABOLOMICS, BY REGION, 2023-2030 (USD MILLION)
TABLE 23 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR OTHERS, BY REGION, 2023-2030 (USD MILLION)
TABLE 24 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR END USER, BY REGION, 2023-2030 (USD MILLION)
TABLE 25 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
TABLE 26 LOBAL DRUG DISCOVERY SERVICES MARKET, FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
TABLE 27 GLOBAL DRUG DISCOVERY SERVICES MARKET, FOR OTHERS, BY REGION, 2023-2030 (USD MILLION)
TABLE 28 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 29 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 30 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 31 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2023-2030 (USD MILLION)
TABLE 32 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 33 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 34 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 35 US: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 36 US: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)
TABLE 37 US: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 38 US: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 39 US: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 40 CANADA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 41 CANADA: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)
TABLE 42 CANADA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 43 CANADA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 44 CANADA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 45 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 46 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 47 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)
TABLE 48 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 49 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 50 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 51 GERMANY: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 52 GERMANY: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)
TABLE 53 GERMANY: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 54 GERMANY: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 55 GERMANY: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 56 FRANCE: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 57 FRANCE: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)
TABLE 58 FRANCE: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 59 FRANCE: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 60 FRANCE: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 61 UK: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 62 UK: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)
TABLE 63 UK: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 64 UK: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 65 UK: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 66 ITALY: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 67 ITALY: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)
TABLE 68 ITALY: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 69 ITALY: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 70 ITALY: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 71 SPAIN: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 72 SPAIN: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)
TABLE 73 SPAIN: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 74 SPAIN: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 75 SPAIN: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 76 REST OF EUROPE: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 77 REST OF EUROPE: DRUG DISCOVERY SERVICES MARKET, BY TYPE OF SERVICES, 2023-2030 (USD MILLION)
TABLE 78 REST OF EUROPE: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 79 REST OF EUROPE: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 80 REST OF EUROPE: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 81 ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
TABLE 82 ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 83 ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 84 ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 85 ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 86 ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 87 CHINA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 88 CHINA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 89 CHINA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 90 CHINA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 91 CHINA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 92 JAPAN: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 93 JAPAN: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 94 JAPAN: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 95 JAPAN: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 96 JAPAN: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 97 INDIA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 98 INDIA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 99 INDIA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 100 INDIA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 101 INDIA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 102 AUSTRALIA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 103 AUSTRALIA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 104 AUSTRALIA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 105 AUSTRALIA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 106 AUSTRALIA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 107 SOUTH KOREA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 108 SOUTH KOREA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 109 SOUTH KOREA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 110 SOUTH KOREA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 111 SOUTH KOREA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 112 REST OF ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 113 REST OF ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 114 REST OF ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 115 REST OF ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 116 REST OF ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 117 REST OF THE WORLD: DRUG DISCOVERY SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
TABLE 118 REST OF THE WORLD: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 119 REST OF THE WORLD: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 120 REST OF THE WORLD: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 121 REST OF THE WORLD: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 122 REST OF THE WORLD: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 123 MIDDLE EAST: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 124 MIDDLE EAST: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 125 MIDDLE EAST: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 126 MIDDLE EAST: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 127 MIDDLE EAST: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 128 AFRICA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 129 AFRICA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 130 AFRICA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 131 AFRICA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 132 AFRICA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 133 LATIN AMERICA: DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
TABLE 134 LATIN AMERICA: DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2018-2030 (USD MILLION)
TABLE 135 LATIN AMERICA: DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
TABLE 136 LATIN AMERICA: DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
TABLE 137 LATIN AMERICA: DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
TABLE 138 MAJOR MANUFACTURERS IN DRUG DISCOVERY SERVICES MARKET
TABLE 139 MOST ACTIVE PLAYER IN DRUG DISCOVERY SERVICES MARKET
TABLE 140 SERVICE LAUNCH
TABLE 141 MERGERS & ACQUISITIONS
TABLE 142 PARTNERSHIP/COLLABORATION
TABLE 143 THERMO FISHER SCIENTIFIC INC.: SERVICES OFFERED
TABLE 144 ARAGEN LIFE SCIENCES PVT. LTD.: SERVICES OFFERED
TABLE 145 ARAGEN LIFE SCIENCES PVT.: KEY DEVELOPMENTS
TABLE 146 PIRAMAL PHARMA SOLUTIONS: SERVICES OFFERED
TABLE 147 CURIA GLOBAL, INC.: SERVICES OFFERED
TABLE 148 CURIA GLOBAL, INC.: KEY DEVELOPMENTS
TABLE 149 CHARLES RIVER LABORATORIES: SERVICES OFFERED
TABLE 150 CHARLES RIVER LABORATORIES: KEY DEVELOPMENTS
TABLE 151 EUROFINS SCIENTIFIC: SERVICES OFFERED
TABLE 152 EUROFINS SCIENTIFIC: KEY DEVELOPMENTS
TABLE 153 IQVIA: SERVICES OFFERED
TABLE 154 EVOTEC: SERVICES OFFERED
TABLE 155 EVOTEC: KEY DEVELOPMENTS
TABLE 156 WUXI APPTEC CO., LTD.: SERVICES OFFERED
TABLE 157 WUXI APPTEC CO., LTD.: KEY DEVELOPMENTS
TABLE 158 LABORATORY CORPORATION OF AMERICA HOLDINGS: SERVICES OFFERED
TABLE 159 SELVITA: SERVICES OFFERED
TABLE 160 SELVITA: KEY DEVELOPMENTS
TABLE 161 SYGNATURE DISCOVERY: SERVICES OFFERED
TABLE 162 SYGNATURE DISCOVERY: KEY DEVELOPMENTS
TABLE 163 SYMERES: SERVICES OFFERED
TABLE 164 SYMERES: KEY DEVELOPMENTS
TABLE 165 NUCHEM SCIENCES INC.: SERVICES OFFERED
TABLE 166 NUCHEM SCIENCES INC.: KEY DEVELOPMENTS
TABLE 167 PARAZA PHARMA, INC.: SERVICES OFFERED
LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 GLOBAL DRUG DISCOVERY SERVICES MARKET
FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES
FIGURE 4 MARKET DYNAMICS: GLOBAL DRUG DISCOVERY SERVICES MARKET
FIGURE 5 DRIVER IMPACT ANALYSIS
FIGURE 6 RESTRAINT IMPACT ANALYSIS
FIGURE 7 VALUE CHAIN ANALYSIS: GLOBAL DRUG DISCOVERY SERVICES MARKET
FIGURE 8 PORTER'S FIVE FORCES ANALYSIS: GLOBAL DRUG DISCOVERY SERVICES MARKET
FIGURE 9 GLOBAL DRUG DISCOVERY SERVICES MARKET SHARE (%), BY DRUG TYPE, 2021
FIGURE 10 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY DRUG TYPE, 2023-2030 (USD MILLION)
FIGURE 11 GLOBAL DRUG DISCOVERY SERVICES MARKET SHARE (%), BY TYPES OF SERVICES, 2021
FIGURE 12 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY TYPES OF SERVICES, 2023-2030 (USD MILLION)
FIGURE 13 GLOBAL DRUG DISCOVERY SERVICES MARKET SHARE (%), BY THERAPEUTIC AREA, 2021
FIGURE 14 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY THERAPEUTIC AREA, 2023-2030 (USD MILLION)
FIGURE 15 GLOBAL DRUG DISCOVERY SERVICES MARKET SHARE (%), BY TECHNOLOGY, 2021
FIGURE 16 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY TECHNOLOGY, 2023-2030 (USD MILLION)
FIGURE 17 GLOBAL DRUG DISCOVERY SERVICES MARKET SHARE (%), BY END USER, 2021
FIGURE 18 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY END USER, 2023-2030 (USD MILLION)
FIGURE 19 GLOBAL DRUG DISCOVERY SERVICES MARKET SHARE (%), BY REGION, 2021
FIGURE 20 GLOBAL DRUG DISCOVERY SERVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
FIGURE 21 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET SHARE (%), BY COUNTRY, 2021
FIGURE 22 EUROPE DRUG DISCOVERY SERVICES MARKET SHARE (%), BY COUNTRY, 2021
FIGURE 23 ASIA-PACIFIC: DRUG DISCOVERY SERVICES MARKET SHARE (%), BY COUNTRY, 2021
FIGURE 24 REST OF THE WORLD: DRUG DISCOVERY SERVICES MARKET SHARE (%), BY REGION, 2021
FIGURE 25 BENCHMARKING OF MAJOR COMPETITORS
FIGURE 26 MAJOR STRATEGY ADOPTED BY KEY PLAYERS IN DRUG DISCOVERY SERVICES MARKET
FIGURE 27 MAJOR PLAYERS SALES & OPERATING INCOME, 2021
FIGURE 28 MAJOR PLAYERS R&D EXPENDITURE, 2021
FIGURE 29 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS
FIGURE 31 PIRAMAL PHARMA SOLUTIONS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 CHARLES RIVER LABORATORIES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 33 CHARLES RIVER LABORATORIES: SWOT ANALYSIS
FIGURE 34 EUROFINS SCIENTIFIC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 35 EUROFINS SCIENTIFIC: SWOT ANALYSIS
FIGURE 36 IQVIA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 37 IQVIA: SWOT ANALYSIS
FIGURE 38 EVOTEC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 39 WUXI APPTEC CO., LTD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 40 WUXI APPTEC CO., LTD.: SWOT ANALYSIS
FIGURE 41 LABORATORY CORPORATION OF AMERICA HOLDINGS: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 42 SELVITA: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 43 SELVITA: SWOT ANALYSIS
FIGURE 44 SYGNATURE DISCOVERY: SWOT ANALYSIS
FIGURE 45 SYMERES: SWOT ANALYSIS
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security